glp-1 ampk Activation of by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice appetite control Novel Insights into the Roles
Description
For weight management medications like Wegovy, discontinuation at least two months before a planned pregnancy is advised
A pivotal 2021 clinical trial of semaglutide showed that participants lost an average of 15% of their body weight over 68 weeks, compared to just 2% in the placebo group
10.4088/JCP.23m15068
Informed consent was not required since the data only included register data
It lowers body weight through reduced food intake
This effect is often the desired outcome for those taking this medication, yet additional considerations exist in practice and warrant clinical management
